GRAL
GRAIL Inc. · Healthcare · Medical - Diagnostics & Research
动量输入（同类管理人）：
持有人广度 +20.0% ·
股份流向 +9.0% ·
净新建仓位 +16.7%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 25.97K | $3.44M | n/a | n/a |
| Q2 2026 | 110 | +3 | 19.61M | $1.34B | +13 | −10 |
| Q1 2026 | 110 | -6 | 18.56M | $959.35M | +4 | −11 |
| Q4 2025 | 117 | +2 | 17.78M | $1.52B | +3 | n/a |
| Q3 2025 | 18 | +1 | 10.99M | $649.07M | +2 | −2 |
| Q2 2025 | 15 | -1 | 10.50M | $537.63M | +1 | −2 |
| Q1 2025 | 13 | +1 | 6.08M | $155.14M | +2 | −1 |
| Q4 2024 | 12 | +2 | 5.32M | $94.90M | +3 | −1 |
| Q3 2024 | 9 | -6 | 3.74M | $51.49M | n/a | −6 |
| Q2 2024 | 15 | n/a | 4.39M | $67.54M | n/a | n/a |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 2.08M | -4.7% | $37.12M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (被动) | 1.14M | n/a | $20.29M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | AQR Capital Management ✦ | 830.72K | +71.0% | $14.83M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 4 | Geode Capital Management ✦ (被动) | 443.56K | +4.6% | $7.92M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | Millennium Management ✦ | 295.52K | +41.8% | $5.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 282.84K | +295.8% | $5.05M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 7 | Two Sigma Investments ✦ | 96.63K | 新增 | $1.72M | 0.0% | New | 1 | SEC ↗ |
| 8 | Norges Bank ✦ (被动) | 66.34K | 0.0% | $1.18M | 0.0% | Held | 3 | SEC ↗ |
| 9 | GAMCO Investors ✦ | 25.90K | -2.6% | $462,315 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 24.52K | +21.7% | $438,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 22.86K | 新增 | $408,051 | 0.0% | New | 1 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 11.50K | 新增 | $205,293 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Two Sigma Investments | $1.72M | 0.0% |
| Wellington Management | $408,051 | 0.0% |
| Arrowstreet Capital | $205,293 | 0.0% |
已清仓
| Marshall Wace | $3.53M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 9.40K 股份, $485 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer, Director · 6.03K 股 · $830,465
Officer, Director · 7.05K 股 · $964,946
Officer, Director · 2.11K 股 · $293,394
Officer, Director · 400 股 · $53,247
Officer, Director · 1.00K 股 · $134,384
Officer, Director · 3.40K 股 · $460,508
Officer · 23.62K 股 · $3.46M
Officer · 7.87K 股 · $1.15M
Officer, Director · 10.00K 股 · $1.10M
Officer, Director · 2.10K 股 · $211,429
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论